カテゴリー： 世界, 部品/材料, LP Information

世界のウシヘパリン市場予測 2023年-2029年

【英語タイトル】Global Bovine Heparin Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC00501）・商品コード：LP23DC00501
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のウシヘパリン市場」は、過去の販売実績から2022年の世界のウシヘパリンの総販売量を検討し、2023年から2029年の予測されるウシヘパリンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のウシヘパリンの市場規模を掲載し、XXX百万米ドル規模の世界のウシヘパリン市場の詳細な分析を提供します。本インサイトレポートは、世界のウシヘパリン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のウシヘパリン市場における各社の独自のポジションをより深く理解するために、ウシヘパリン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のウシヘパリン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ウシヘパリンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。ウシヘパリンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ウシヘパリンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ウシヘパリンの世界主要メーカーとしては、Pfizer、 Bioibérica、 Opocrin、 Yino Pharma、 Cisen Pharmaceutical、 Sichuan Deebio Pharmaceutical、 Shenzhen Hepalink Pharmaceutical、 Yantai Dongcheng Pharmaceutical、 Nanjing King-friend Biochemical Pharmaceutical、 Hebei Changshan Biochemical Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のウシヘパリン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではウシヘパリン市場をセグメンテーションし、種類別 (未分画ヘパリン、低分子ヘパリン)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：未分画ヘパリン、低分子ヘパリン

・用途別区分：病院、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のウシヘパリン市場の10年間の市場状況・展望は？
・世界および地域別に見たウシヘパリン市場成長の要因は何か？
・ウシヘパリンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・ウシヘパリンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：ウシヘパリンの年間販売量2018-2029、地域別現状・将来分析
・ウシヘパリンの種類別セグメント：未分画ヘパリン、低分子ヘパリン
・ウシヘパリンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・ウシヘパリンの用途別セグメント：病院、診療所、その他
・ウシヘパリンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のウシヘパリン市場
・企業別のグローバルウシヘパリン市場データ：2018-2023年の年間販売量、市場シェア
・企業別のウシヘパリンの年間売上：2018-2023年の売上、市場シェア
・企業別のウシヘパリン販売価格
・主要企業のウシヘパリン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ウシヘパリンの地域別レビュー
・地域別のウシヘパリン市場規模2018-2023：年間販売量、売上
・主要国別のウシヘパリン市場規模2018-2023：年間販売量、売上
・南北アメリカのウシヘパリン販売の成長
・アジア太平洋のウシヘパリン販売の成長
・ヨーロッパのウシヘパリン販売の成長
・中東・アフリカのウシヘパリン販売の成長

南北アメリカ市場
・南北アメリカの国別のウシヘパリン販売量、売上（2018-2023）
・南北アメリカのウシヘパリンの種類別販売量
・南北アメリカのウシヘパリンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のウシヘパリン販売量、売上（2018-2023）
・アジア太平洋のウシヘパリンの種類別販売量
・アジア太平洋のウシヘパリンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のウシヘパリン販売量、売上（2018-2023）
・ヨーロッパのウシヘパリンの種類別販売量
・ヨーロッパのウシヘパリンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のウシヘパリン販売量、売上（2018-2023）
・中東・アフリカのウシヘパリンの種類別販売量
・中東・アフリカのウシヘパリンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ウシヘパリンの製造コスト構造分析
・ウシヘパリンの製造プロセス分析
・ウシヘパリンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・ウシヘパリンの主要なグローバル販売業者
・ウシヘパリンの主要なグローバル顧客

地域別のウシヘパリン市場予測レビュー
・地域別のウシヘパリン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ウシヘパリンの種類別市場規模予測
・ウシヘパリンの用途別市場規模予測

主要企業分析
Pfizer、 Bioibérica、 Opocrin、 Yino Pharma、 Cisen Pharmaceutical、 Sichuan Deebio Pharmaceutical、 Shenzhen Hepalink Pharmaceutical、 Yantai Dongcheng Pharmaceutical、 Nanjing King-friend Biochemical Pharmaceutical、 Hebei Changshan Biochemical Pharmaceutical
・企業情報
・ウシヘパリン製品
・ウシヘパリン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Bovine Heparin market size is projected to grow from US$ 4489.5 million in 2022 to US$ 5485.8 million in 2029; it is expected to grow at a CAGR of 2.9% from 2023 to 2029.
United States market for Bovine Heparin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Bovine Heparin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Bovine Heparin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Bovine Heparin players cover Pfizer, Bioibérica, Opocrin, Yino Pharma, Cisen Pharmaceutical, Sichuan Deebio Pharmaceutical, Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical and Nanjing King-friend Biochemical Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Bovine Heparin is a medical material extracted from lung of cow.
LPI (LP Information)’ newest research report, the “Bovine Heparin Industry Forecast” looks at past sales and reviews total world Bovine Heparin sales in 2022, providing a comprehensive analysis by region and market sector of projected Bovine Heparin sales for 2023 through 2029. With Bovine Heparin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bovine Heparin industry.
This Insight Report provides a comprehensive analysis of the global Bovine Heparin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bovine Heparin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bovine Heparin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bovine Heparin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bovine Heparin.
This report presents a comprehensive overview, market shares, and growth opportunities of Bovine Heparin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Unfractionated Heparin
Low Molecular Weight Heparin
Segmentation by application
Hospital
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Pfizer
Bioibérica
Opocrin
Yino Pharma
Cisen Pharmaceutical
Sichuan Deebio Pharmaceutical
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bovine Heparin market?
What factors are driving Bovine Heparin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bovine Heparin market opportunities vary by end market size?
How does Bovine Heparin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bovine Heparin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Bovine Heparin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Bovine Heparin by Country/Region, 2018, 2022 & 2029
2.2 Bovine Heparin Segment by Type
2.2.1 Unfractionated Heparin
2.2.2 Low Molecular Weight Heparin
2.3 Bovine Heparin Sales by Type
2.3.1 Global Bovine Heparin Sales Market Share by Type (2018-2023)
2.3.2 Global Bovine Heparin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Bovine Heparin Sale Price by Type (2018-2023)
2.4 Bovine Heparin Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Others
2.5 Bovine Heparin Sales by Application
2.5.1 Global Bovine Heparin Sale Market Share by Application (2018-2023)
2.5.2 Global Bovine Heparin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Bovine Heparin Sale Price by Application (2018-2023)
3 Global Bovine Heparin by Company
3.1 Global Bovine Heparin Breakdown Data by Company
3.1.1 Global Bovine Heparin Annual Sales by Company (2018-2023)
3.1.2 Global Bovine Heparin Sales Market Share by Company (2018-2023)
3.2 Global Bovine Heparin Annual Revenue by Company (2018-2023)
3.2.1 Global Bovine Heparin Revenue by Company (2018-2023)
3.2.2 Global Bovine Heparin Revenue Market Share by Company (2018-2023)
3.3 Global Bovine Heparin Sale Price by Company
3.4 Key Manufacturers Bovine Heparin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bovine Heparin Product Location Distribution
3.4.2 Players Bovine Heparin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bovine Heparin by Geographic Region
4.1 World Historic Bovine Heparin Market Size by Geographic Region (2018-2023)
4.1.1 Global Bovine Heparin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Bovine Heparin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bovine Heparin Market Size by Country/Region (2018-2023)
4.2.1 Global Bovine Heparin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Bovine Heparin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bovine Heparin Sales Growth
4.4 APAC Bovine Heparin Sales Growth
4.5 Europe Bovine Heparin Sales Growth
4.6 Middle East & Africa Bovine Heparin Sales Growth
5 Americas
5.1 Americas Bovine Heparin Sales by Country
5.1.1 Americas Bovine Heparin Sales by Country (2018-2023)
5.1.2 Americas Bovine Heparin Revenue by Country (2018-2023)
5.2 Americas Bovine Heparin Sales by Type
5.3 Americas Bovine Heparin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bovine Heparin Sales by Region
6.1.1 APAC Bovine Heparin Sales by Region (2018-2023)
6.1.2 APAC Bovine Heparin Revenue by Region (2018-2023)
6.2 APAC Bovine Heparin Sales by Type
6.3 APAC Bovine Heparin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bovine Heparin by Country
7.1.1 Europe Bovine Heparin Sales by Country (2018-2023)
7.1.2 Europe Bovine Heparin Revenue by Country (2018-2023)
7.2 Europe Bovine Heparin Sales by Type
7.3 Europe Bovine Heparin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bovine Heparin by Country
8.1.1 Middle East & Africa Bovine Heparin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Bovine Heparin Revenue by Country (2018-2023)
8.2 Middle East & Africa Bovine Heparin Sales by Type
8.3 Middle East & Africa Bovine Heparin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bovine Heparin
10.3 Manufacturing Process Analysis of Bovine Heparin
10.4 Industry Chain Structure of Bovine Heparin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bovine Heparin Distributors
11.3 Bovine Heparin Customer
12 World Forecast Review for Bovine Heparin by Geographic Region
12.1 Global Bovine Heparin Market Size Forecast by Region
12.1.1 Global Bovine Heparin Forecast by Region (2024-2029)
12.1.2 Global Bovine Heparin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bovine Heparin Forecast by Type
12.7 Global Bovine Heparin Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Bovine Heparin Product Portfolios and Specifications
13.1.3 Pfizer Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Bioibérica
13.2.1 Bioibérica Company Information
13.2.2 Bioibérica Bovine Heparin Product Portfolios and Specifications
13.2.3 Bioibérica Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bioibérica Main Business Overview
13.2.5 Bioibérica Latest Developments
13.3 Opocrin
13.3.1 Opocrin Company Information
13.3.2 Opocrin Bovine Heparin Product Portfolios and Specifications
13.3.3 Opocrin Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Opocrin Main Business Overview
13.3.5 Opocrin Latest Developments
13.4 Yino Pharma
13.4.1 Yino Pharma Company Information
13.4.2 Yino Pharma Bovine Heparin Product Portfolios and Specifications
13.4.3 Yino Pharma Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Yino Pharma Main Business Overview
13.4.5 Yino Pharma Latest Developments
13.5 Cisen Pharmaceutical
13.5.1 Cisen Pharmaceutical Company Information
13.5.2 Cisen Pharmaceutical Bovine Heparin Product Portfolios and Specifications
13.5.3 Cisen Pharmaceutical Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cisen Pharmaceutical Main Business Overview
13.5.5 Cisen Pharmaceutical Latest Developments
13.6 Sichuan Deebio Pharmaceutical
13.6.1 Sichuan Deebio Pharmaceutical Company Information
13.6.2 Sichuan Deebio Pharmaceutical Bovine Heparin Product Portfolios and Specifications
13.6.3 Sichuan Deebio Pharmaceutical Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sichuan Deebio Pharmaceutical Main Business Overview
13.6.5 Sichuan Deebio Pharmaceutical Latest Developments
13.7 Shenzhen Hepalink Pharmaceutical
13.7.1 Shenzhen Hepalink Pharmaceutical Company Information
13.7.2 Shenzhen Hepalink Pharmaceutical Bovine Heparin Product Portfolios and Specifications
13.7.3 Shenzhen Hepalink Pharmaceutical Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Shenzhen Hepalink Pharmaceutical Main Business Overview
13.7.5 Shenzhen Hepalink Pharmaceutical Latest Developments
13.8 Yantai Dongcheng Pharmaceutical
13.8.1 Yantai Dongcheng Pharmaceutical Company Information
13.8.2 Yantai Dongcheng Pharmaceutical Bovine Heparin Product Portfolios and Specifications
13.8.3 Yantai Dongcheng Pharmaceutical Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Yantai Dongcheng Pharmaceutical Main Business Overview
13.8.5 Yantai Dongcheng Pharmaceutical Latest Developments
13.9 Nanjing King-friend Biochemical Pharmaceutical
13.9.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
13.9.2 Nanjing King-friend Biochemical Pharmaceutical Bovine Heparin Product Portfolios and Specifications
13.9.3 Nanjing King-friend Biochemical Pharmaceutical Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Nanjing King-friend Biochemical Pharmaceutical Main Business Overview
13.9.5 Nanjing King-friend Biochemical Pharmaceutical Latest Developments
13.10 Hebei Changshan Biochemical Pharmaceutical
13.10.1 Hebei Changshan Biochemical Pharmaceutical Company Information
13.10.2 Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Product Portfolios and Specifications
13.10.3 Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hebei Changshan Biochemical Pharmaceutical Main Business Overview
13.10.5 Hebei Changshan Biochemical Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Bovine Heparin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Bovine Heparin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Unfractionated Heparin
Table 4. Major Players of Low Molecular Weight Heparin
Table 5. Global Bovine Heparin Sales by Type (2018-2023) & (Tons)
Table 6. Global Bovine Heparin Sales Market Share by Type (2018-2023)
Table 7. Global Bovine Heparin Revenue by Type (2018-2023) & ($ million)
Table 8. Global Bovine Heparin Revenue Market Share by Type (2018-2023)
Table 9. Global Bovine Heparin Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Bovine Heparin Sales by Application (2018-2023) & (Tons)
Table 11. Global Bovine Heparin Sales Market Share by Application (2018-2023)
Table 12. Global Bovine Heparin Revenue by Application (2018-2023)
Table 13. Global Bovine Heparin Revenue Market Share by Application (2018-2023)
Table 14. Global Bovine Heparin Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Bovine Heparin Sales by Company (2018-2023) & (Tons)
Table 16. Global Bovine Heparin Sales Market Share by Company (2018-2023)
Table 17. Global Bovine Heparin Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Bovine Heparin Revenue Market Share by Company (2018-2023)
Table 19. Global Bovine Heparin Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Bovine Heparin Producing Area Distribution and Sales Area
Table 21. Players Bovine Heparin Products Offered
Table 22. Bovine Heparin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bovine Heparin Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Bovine Heparin Sales Market Share Geographic Region (2018-2023)
Table 27. Global Bovine Heparin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Bovine Heparin Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Bovine Heparin Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Bovine Heparin Sales Market Share by Country/Region (2018-2023)
Table 31. Global Bovine Heparin Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Bovine Heparin Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Bovine Heparin Sales by Country (2018-2023) & (Tons)
Table 34. Americas Bovine Heparin Sales Market Share by Country (2018-2023)
Table 35. Americas Bovine Heparin Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Bovine Heparin Revenue Market Share by Country (2018-2023)
Table 37. Americas Bovine Heparin Sales by Type (2018-2023) & (Tons)
Table 38. Americas Bovine Heparin Sales by Application (2018-2023) & (Tons)
Table 39. APAC Bovine Heparin Sales by Region (2018-2023) & (Tons)
Table 40. APAC Bovine Heparin Sales Market Share by Region (2018-2023)
Table 41. APAC Bovine Heparin Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Bovine Heparin Revenue Market Share by Region (2018-2023)
Table 43. APAC Bovine Heparin Sales by Type (2018-2023) & (Tons)
Table 44. APAC Bovine Heparin Sales by Application (2018-2023) & (Tons)
Table 45. Europe Bovine Heparin Sales by Country (2018-2023) & (Tons)
Table 46. Europe Bovine Heparin Sales Market Share by Country (2018-2023)
Table 47. Europe Bovine Heparin Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Bovine Heparin Revenue Market Share by Country (2018-2023)
Table 49. Europe Bovine Heparin Sales by Type (2018-2023) & (Tons)
Table 50. Europe Bovine Heparin Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Bovine Heparin Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Bovine Heparin Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Bovine Heparin Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Bovine Heparin Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Bovine Heparin Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Bovine Heparin Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Bovine Heparin
Table 58. Key Market Challenges & Risks of Bovine Heparin
Table 59. Key Industry Trends of Bovine Heparin
Table 60. Bovine Heparin Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Bovine Heparin Distributors List
Table 63. Bovine Heparin Customer List
Table 64. Global Bovine Heparin Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Bovine Heparin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Bovine Heparin Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Bovine Heparin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Bovine Heparin Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Bovine Heparin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Bovine Heparin Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Bovine Heparin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Bovine Heparin Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Bovine Heparin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Bovine Heparin Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Bovine Heparin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Bovine Heparin Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Bovine Heparin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Pfizer Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Bovine Heparin Product Portfolios and Specifications
Table 80. Pfizer Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. Bioibérica Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 84. Bioibérica Bovine Heparin Product Portfolios and Specifications
Table 85. Bioibérica Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Bioibérica Main Business
Table 87. Bioibérica Latest Developments
Table 88. Opocrin Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 89. Opocrin Bovine Heparin Product Portfolios and Specifications
Table 90. Opocrin Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Opocrin Main Business
Table 92. Opocrin Latest Developments
Table 93. Yino Pharma Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 94. Yino Pharma Bovine Heparin Product Portfolios and Specifications
Table 95. Yino Pharma Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Yino Pharma Main Business
Table 97. Yino Pharma Latest Developments
Table 98. Cisen Pharmaceutical Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 99. Cisen Pharmaceutical Bovine Heparin Product Portfolios and Specifications
Table 100. Cisen Pharmaceutical Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Cisen Pharmaceutical Main Business
Table 102. Cisen Pharmaceutical Latest Developments
Table 103. Sichuan Deebio Pharmaceutical Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 104. Sichuan Deebio Pharmaceutical Bovine Heparin Product Portfolios and Specifications
Table 105. Sichuan Deebio Pharmaceutical Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Sichuan Deebio Pharmaceutical Main Business
Table 107. Sichuan Deebio Pharmaceutical Latest Developments
Table 108. Shenzhen Hepalink Pharmaceutical Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 109. Shenzhen Hepalink Pharmaceutical Bovine Heparin Product Portfolios and Specifications
Table 110. Shenzhen Hepalink Pharmaceutical Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Shenzhen Hepalink Pharmaceutical Main Business
Table 112. Shenzhen Hepalink Pharmaceutical Latest Developments
Table 113. Yantai Dongcheng Pharmaceutical Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 114. Yantai Dongcheng Pharmaceutical Bovine Heparin Product Portfolios and Specifications
Table 115. Yantai Dongcheng Pharmaceutical Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Yantai Dongcheng Pharmaceutical Main Business
Table 117. Yantai Dongcheng Pharmaceutical Latest Developments
Table 118. Nanjing King-friend Biochemical Pharmaceutical Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 119. Nanjing King-friend Biochemical Pharmaceutical Bovine Heparin Product Portfolios and Specifications
Table 120. Nanjing King-friend Biochemical Pharmaceutical Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Nanjing King-friend Biochemical Pharmaceutical Main Business
Table 122. Nanjing King-friend Biochemical Pharmaceutical Latest Developments
Table 123. Hebei Changshan Biochemical Pharmaceutical Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 124. Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Product Portfolios and Specifications
Table 125. Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Hebei Changshan Biochemical Pharmaceutical Main Business
Table 127. Hebei Changshan Biochemical Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Bovine Heparin
Figure 2. Bovine Heparin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bovine Heparin Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Bovine Heparin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Bovine Heparin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Unfractionated Heparin
Figure 10. Product Picture of Low Molecular Weight Heparin
Figure 11. Global Bovine Heparin Sales Market Share by Type in 2022
Figure 12. Global Bovine Heparin Revenue Market Share by Type (2018-2023)
Figure 13. Bovine Heparin Consumed in Hospital
Figure 14. Global Bovine Heparin Market: Hospital (2018-2023) & (Tons)
Figure 15. Bovine Heparin Consumed in Clinics
Figure 16. Global Bovine Heparin Market: Clinics (2018-2023) & (Tons)
Figure 17. Bovine Heparin Consumed in Others
Figure 18. Global Bovine Heparin Market: Others (2018-2023) & (Tons)
Figure 19. Global Bovine Heparin Sales Market Share by Application (2022)
Figure 20. Global Bovine Heparin Revenue Market Share by Application in 2022
Figure 21. Bovine Heparin Sales Market by Company in 2022 (Tons)
Figure 22. Global Bovine Heparin Sales Market Share by Company in 2022
Figure 23. Bovine Heparin Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Bovine Heparin Revenue Market Share by Company in 2022
Figure 25. Global Bovine Heparin Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Bovine Heparin Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Bovine Heparin Sales 2018-2023 (Tons)
Figure 28. Americas Bovine Heparin Revenue 2018-2023 ($ Millions)
Figure 29. APAC Bovine Heparin Sales 2018-2023 (Tons)
Figure 30. APAC Bovine Heparin Revenue 2018-2023 ($ Millions)
Figure 31. Europe Bovine Heparin Sales 2018-2023 (Tons)
Figure 32. Europe Bovine Heparin Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Bovine Heparin Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa Bovine Heparin Revenue 2018-2023 ($ Millions)
Figure 35. Americas Bovine Heparin Sales Market Share by Country in 2022
Figure 36. Americas Bovine Heparin Revenue Market Share by Country in 2022
Figure 37. Americas Bovine Heparin Sales Market Share by Type (2018-2023)
Figure 38. Americas Bovine Heparin Sales Market Share by Application (2018-2023)
Figure 39. United States Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Bovine Heparin Sales Market Share by Region in 2022
Figure 44. APAC Bovine Heparin Revenue Market Share by Regions in 2022
Figure 45. APAC Bovine Heparin Sales Market Share by Type (2018-2023)
Figure 46. APAC Bovine Heparin Sales Market Share by Application (2018-2023)
Figure 47. China Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Bovine Heparin Sales Market Share by Country in 2022
Figure 55. Europe Bovine Heparin Revenue Market Share by Country in 2022
Figure 56. Europe Bovine Heparin Sales Market Share by Type (2018-2023)
Figure 57. Europe Bovine Heparin Sales Market Share by Application (2018-2023)
Figure 58. Germany Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Bovine Heparin Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Bovine Heparin Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Bovine Heparin Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Bovine Heparin Sales Market Share by Application (2018-2023)
Figure 67. Egypt Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Bovine Heparin in 2022
Figure 73. Manufacturing Process Analysis of Bovine Heparin
Figure 74. Industry Chain Structure of Bovine Heparin
Figure 75. Channels of Distribution
Figure 76. Global Bovine Heparin Sales Market Forecast by Region (2024-2029)
Figure 77. Global Bovine Heparin Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Bovine Heparin Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Bovine Heparin Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Bovine Heparin Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Bovine Heparin Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のウシヘパリン市場予測 2023年-2029年] (コード：LP23DC00501)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のウシヘパリン市場予測 2023年-2029年]についてメールでお問い合わせ
カテゴリー： 世界, 部品/材料, LP Information

世界のウシヘパリン市場予測 2023年-2029年

【英語タイトル】Global Bovine Heparin Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC00501）・商品コード：LP23DC00501
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のウシヘパリン市場」は、過去の販売実績から2022年の世界のウシヘパリンの総販売量を検討し、2023年から2029年の予測されるウシヘパリンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のウシヘパリンの市場規模を掲載し、XXX百万米ドル規模の世界のウシヘパリン市場の詳細な分析を提供します。本インサイトレポートは、世界のウシヘパリン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のウシヘパリン市場における各社の独自のポジションをより深く理解するために、ウシヘパリン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のウシヘパリン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ウシヘパリンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。ウシヘパリンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ウシヘパリンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ウシヘパリンの世界主要メーカーとしては、Pfizer、 Bioibérica、 Opocrin、 Yino Pharma、 Cisen Pharmaceutical、 Sichuan Deebio Pharmaceutical、 Shenzhen Hepalink Pharmaceutical、 Yantai Dongcheng Pharmaceutical、 Nanjing King-friend Biochemical Pharmaceutical、 Hebei Changshan Biochemical Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のウシヘパリン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではウシヘパリン市場をセグメンテーションし、種類別 (未分画ヘパリン、低分子ヘパリン)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：未分画ヘパリン、低分子ヘパリン

・用途別区分：病院、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のウシヘパリン市場の10年間の市場状況・展望は？
・世界および地域別に見たウシヘパリン市場成長の要因は何か？
・ウシヘパリンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・ウシヘパリンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：ウシヘパリンの年間販売量2018-2029、地域別現状・将来分析
・ウシヘパリンの種類別セグメント：未分画ヘパリン、低分子ヘパリン
・ウシヘパリンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・ウシヘパリンの用途別セグメント：病院、診療所、その他
・ウシヘパリンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のウシヘパリン市場
・企業別のグローバルウシヘパリン市場データ：2018-2023年の年間販売量、市場シェア
・企業別のウシヘパリンの年間売上：2018-2023年の売上、市場シェア
・企業別のウシヘパリン販売価格
・主要企業のウシヘパリン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ウシヘパリンの地域別レビュー
・地域別のウシヘパリン市場規模2018-2023：年間販売量、売上
・主要国別のウシヘパリン市場規模2018-2023：年間販売量、売上
・南北アメリカのウシヘパリン販売の成長
・アジア太平洋のウシヘパリン販売の成長
・ヨーロッパのウシヘパリン販売の成長
・中東・アフリカのウシヘパリン販売の成長

南北アメリカ市場
・南北アメリカの国別のウシヘパリン販売量、売上（2018-2023）
・南北アメリカのウシヘパリンの種類別販売量
・南北アメリカのウシヘパリンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のウシヘパリン販売量、売上（2018-2023）
・アジア太平洋のウシヘパリンの種類別販売量
・アジア太平洋のウシヘパリンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のウシヘパリン販売量、売上（2018-2023）
・ヨーロッパのウシヘパリンの種類別販売量
・ヨーロッパのウシヘパリンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のウシヘパリン販売量、売上（2018-2023）
・中東・アフリカのウシヘパリンの種類別販売量
・中東・アフリカのウシヘパリンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ウシヘパリンの製造コスト構造分析
・ウシヘパリンの製造プロセス分析
・ウシヘパリンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・ウシヘパリンの主要なグローバル販売業者
・ウシヘパリンの主要なグローバル顧客

地域別のウシヘパリン市場予測レビュー
・地域別のウシヘパリン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ウシヘパリンの種類別市場規模予測
・ウシヘパリンの用途別市場規模予測

主要企業分析
Pfizer、 Bioibérica、 Opocrin、 Yino Pharma、 Cisen Pharmaceutical、 Sichuan Deebio Pharmaceutical、 Shenzhen Hepalink Pharmaceutical、 Yantai Dongcheng Pharmaceutical、 Nanjing King-friend Biochemical Pharmaceutical、 Hebei Changshan Biochemical Pharmaceutical
・企業情報
・ウシヘパリン製品
・ウシヘパリン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Bovine Heparin market size is projected to grow from US$ 4489.5 million in 2022 to US$ 5485.8 million in 2029; it is expected to grow at a CAGR of 2.9% from 2023 to 2029.
United States market for Bovine Heparin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Bovine Heparin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Bovine Heparin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Bovine Heparin players cover Pfizer, Bioibérica, Opocrin, Yino Pharma, Cisen Pharmaceutical, Sichuan Deebio Pharmaceutical, Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical and Nanjing King-friend Biochemical Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Bovine Heparin is a medical material extracted from lung of cow.
LPI (LP Information)’ newest research report, the “Bovine Heparin Industry Forecast” looks at past sales and reviews total world Bovine Heparin sales in 2022, providing a comprehensive analysis by region and market sector of projected Bovine Heparin sales for 2023 through 2029. With Bovine Heparin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bovine Heparin industry.
This Insight Report provides a comprehensive analysis of the global Bovine Heparin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bovine Heparin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bovine Heparin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bovine Heparin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bovine Heparin.
This report presents a comprehensive overview, market shares, and growth opportunities of Bovine Heparin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Unfractionated Heparin
Low Molecular Weight Heparin
Segmentation by application
Hospital
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Pfizer
Bioibérica
Opocrin
Yino Pharma
Cisen Pharmaceutical
Sichuan Deebio Pharmaceutical
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bovine Heparin market?
What factors are driving Bovine Heparin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bovine Heparin market opportunities vary by end market size?
How does Bovine Heparin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bovine Heparin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Bovine Heparin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Bovine Heparin by Country/Region, 2018, 2022 & 2029
2.2 Bovine Heparin Segment by Type
2.2.1 Unfractionated Heparin
2.2.2 Low Molecular Weight Heparin
2.3 Bovine Heparin Sales by Type
2.3.1 Global Bovine Heparin Sales Market Share by Type (2018-2023)
2.3.2 Global Bovine Heparin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Bovine Heparin Sale Price by Type (2018-2023)
2.4 Bovine Heparin Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Others
2.5 Bovine Heparin Sales by Application
2.5.1 Global Bovine Heparin Sale Market Share by Application (2018-2023)
2.5.2 Global Bovine Heparin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Bovine Heparin Sale Price by Application (2018-2023)
3 Global Bovine Heparin by Company
3.1 Global Bovine Heparin Breakdown Data by Company
3.1.1 Global Bovine Heparin Annual Sales by Company (2018-2023)
3.1.2 Global Bovine Heparin Sales Market Share by Company (2018-2023)
3.2 Global Bovine Heparin Annual Revenue by Company (2018-2023)
3.2.1 Global Bovine Heparin Revenue by Company (2018-2023)
3.2.2 Global Bovine Heparin Revenue Market Share by Company (2018-2023)
3.3 Global Bovine Heparin Sale Price by Company
3.4 Key Manufacturers Bovine Heparin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bovine Heparin Product Location Distribution
3.4.2 Players Bovine Heparin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bovine Heparin by Geographic Region
4.1 World Historic Bovine Heparin Market Size by Geographic Region (2018-2023)
4.1.1 Global Bovine Heparin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Bovine Heparin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bovine Heparin Market Size by Country/Region (2018-2023)
4.2.1 Global Bovine Heparin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Bovine Heparin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bovine Heparin Sales Growth
4.4 APAC Bovine Heparin Sales Growth
4.5 Europe Bovine Heparin Sales Growth
4.6 Middle East & Africa Bovine Heparin Sales Growth
5 Americas
5.1 Americas Bovine Heparin Sales by Country
5.1.1 Americas Bovine Heparin Sales by Country (2018-2023)
5.1.2 Americas Bovine Heparin Revenue by Country (2018-2023)
5.2 Americas Bovine Heparin Sales by Type
5.3 Americas Bovine Heparin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bovine Heparin Sales by Region
6.1.1 APAC Bovine Heparin Sales by Region (2018-2023)
6.1.2 APAC Bovine Heparin Revenue by Region (2018-2023)
6.2 APAC Bovine Heparin Sales by Type
6.3 APAC Bovine Heparin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bovine Heparin by Country
7.1.1 Europe Bovine Heparin Sales by Country (2018-2023)
7.1.2 Europe Bovine Heparin Revenue by Country (2018-2023)
7.2 Europe Bovine Heparin Sales by Type
7.3 Europe Bovine Heparin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bovine Heparin by Country
8.1.1 Middle East & Africa Bovine Heparin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Bovine Heparin Revenue by Country (2018-2023)
8.2 Middle East & Africa Bovine Heparin Sales by Type
8.3 Middle East & Africa Bovine Heparin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bovine Heparin
10.3 Manufacturing Process Analysis of Bovine Heparin
10.4 Industry Chain Structure of Bovine Heparin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bovine Heparin Distributors
11.3 Bovine Heparin Customer
12 World Forecast Review for Bovine Heparin by Geographic Region
12.1 Global Bovine Heparin Market Size Forecast by Region
12.1.1 Global Bovine Heparin Forecast by Region (2024-2029)
12.1.2 Global Bovine Heparin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bovine Heparin Forecast by Type
12.7 Global Bovine Heparin Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Bovine Heparin Product Portfolios and Specifications
13.1.3 Pfizer Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Bioibérica
13.2.1 Bioibérica Company Information
13.2.2 Bioibérica Bovine Heparin Product Portfolios and Specifications
13.2.3 Bioibérica Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bioibérica Main Business Overview
13.2.5 Bioibérica Latest Developments
13.3 Opocrin
13.3.1 Opocrin Company Information
13.3.2 Opocrin Bovine Heparin Product Portfolios and Specifications
13.3.3 Opocrin Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Opocrin Main Business Overview
13.3.5 Opocrin Latest Developments
13.4 Yino Pharma
13.4.1 Yino Pharma Company Information
13.4.2 Yino Pharma Bovine Heparin Product Portfolios and Specifications
13.4.3 Yino Pharma Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Yino Pharma Main Business Overview
13.4.5 Yino Pharma Latest Developments
13.5 Cisen Pharmaceutical
13.5.1 Cisen Pharmaceutical Company Information
13.5.2 Cisen Pharmaceutical Bovine Heparin Product Portfolios and Specifications
13.5.3 Cisen Pharmaceutical Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cisen Pharmaceutical Main Business Overview
13.5.5 Cisen Pharmaceutical Latest Developments
13.6 Sichuan Deebio Pharmaceutical
13.6.1 Sichuan Deebio Pharmaceutical Company Information
13.6.2 Sichuan Deebio Pharmaceutical Bovine Heparin Product Portfolios and Specifications
13.6.3 Sichuan Deebio Pharmaceutical Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sichuan Deebio Pharmaceutical Main Business Overview
13.6.5 Sichuan Deebio Pharmaceutical Latest Developments
13.7 Shenzhen Hepalink Pharmaceutical
13.7.1 Shenzhen Hepalink Pharmaceutical Company Information
13.7.2 Shenzhen Hepalink Pharmaceutical Bovine Heparin Product Portfolios and Specifications
13.7.3 Shenzhen Hepalink Pharmaceutical Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Shenzhen Hepalink Pharmaceutical Main Business Overview
13.7.5 Shenzhen Hepalink Pharmaceutical Latest Developments
13.8 Yantai Dongcheng Pharmaceutical
13.8.1 Yantai Dongcheng Pharmaceutical Company Information
13.8.2 Yantai Dongcheng Pharmaceutical Bovine Heparin Product Portfolios and Specifications
13.8.3 Yantai Dongcheng Pharmaceutical Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Yantai Dongcheng Pharmaceutical Main Business Overview
13.8.5 Yantai Dongcheng Pharmaceutical Latest Developments
13.9 Nanjing King-friend Biochemical Pharmaceutical
13.9.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
13.9.2 Nanjing King-friend Biochemical Pharmaceutical Bovine Heparin Product Portfolios and Specifications
13.9.3 Nanjing King-friend Biochemical Pharmaceutical Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Nanjing King-friend Biochemical Pharmaceutical Main Business Overview
13.9.5 Nanjing King-friend Biochemical Pharmaceutical Latest Developments
13.10 Hebei Changshan Biochemical Pharmaceutical
13.10.1 Hebei Changshan Biochemical Pharmaceutical Company Information
13.10.2 Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Product Portfolios and Specifications
13.10.3 Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hebei Changshan Biochemical Pharmaceutical Main Business Overview
13.10.5 Hebei Changshan Biochemical Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Bovine Heparin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Bovine Heparin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Unfractionated Heparin
Table 4. Major Players of Low Molecular Weight Heparin
Table 5. Global Bovine Heparin Sales by Type (2018-2023) & (Tons)
Table 6. Global Bovine Heparin Sales Market Share by Type (2018-2023)
Table 7. Global Bovine Heparin Revenue by Type (2018-2023) & ($ million)
Table 8. Global Bovine Heparin Revenue Market Share by Type (2018-2023)
Table 9. Global Bovine Heparin Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Bovine Heparin Sales by Application (2018-2023) & (Tons)
Table 11. Global Bovine Heparin Sales Market Share by Application (2018-2023)
Table 12. Global Bovine Heparin Revenue by Application (2018-2023)
Table 13. Global Bovine Heparin Revenue Market Share by Application (2018-2023)
Table 14. Global Bovine Heparin Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Bovine Heparin Sales by Company (2018-2023) & (Tons)
Table 16. Global Bovine Heparin Sales Market Share by Company (2018-2023)
Table 17. Global Bovine Heparin Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Bovine Heparin Revenue Market Share by Company (2018-2023)
Table 19. Global Bovine Heparin Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Bovine Heparin Producing Area Distribution and Sales Area
Table 21. Players Bovine Heparin Products Offered
Table 22. Bovine Heparin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bovine Heparin Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Bovine Heparin Sales Market Share Geographic Region (2018-2023)
Table 27. Global Bovine Heparin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Bovine Heparin Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Bovine Heparin Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Bovine Heparin Sales Market Share by Country/Region (2018-2023)
Table 31. Global Bovine Heparin Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Bovine Heparin Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Bovine Heparin Sales by Country (2018-2023) & (Tons)
Table 34. Americas Bovine Heparin Sales Market Share by Country (2018-2023)
Table 35. Americas Bovine Heparin Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Bovine Heparin Revenue Market Share by Country (2018-2023)
Table 37. Americas Bovine Heparin Sales by Type (2018-2023) & (Tons)
Table 38. Americas Bovine Heparin Sales by Application (2018-2023) & (Tons)
Table 39. APAC Bovine Heparin Sales by Region (2018-2023) & (Tons)
Table 40. APAC Bovine Heparin Sales Market Share by Region (2018-2023)
Table 41. APAC Bovine Heparin Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Bovine Heparin Revenue Market Share by Region (2018-2023)
Table 43. APAC Bovine Heparin Sales by Type (2018-2023) & (Tons)
Table 44. APAC Bovine Heparin Sales by Application (2018-2023) & (Tons)
Table 45. Europe Bovine Heparin Sales by Country (2018-2023) & (Tons)
Table 46. Europe Bovine Heparin Sales Market Share by Country (2018-2023)
Table 47. Europe Bovine Heparin Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Bovine Heparin Revenue Market Share by Country (2018-2023)
Table 49. Europe Bovine Heparin Sales by Type (2018-2023) & (Tons)
Table 50. Europe Bovine Heparin Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Bovine Heparin Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Bovine Heparin Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Bovine Heparin Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Bovine Heparin Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Bovine Heparin Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Bovine Heparin Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Bovine Heparin
Table 58. Key Market Challenges & Risks of Bovine Heparin
Table 59. Key Industry Trends of Bovine Heparin
Table 60. Bovine Heparin Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Bovine Heparin Distributors List
Table 63. Bovine Heparin Customer List
Table 64. Global Bovine Heparin Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Bovine Heparin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Bovine Heparin Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Bovine Heparin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Bovine Heparin Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Bovine Heparin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Bovine Heparin Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Bovine Heparin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Bovine Heparin Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Bovine Heparin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Bovine Heparin Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Bovine Heparin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Bovine Heparin Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Bovine Heparin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Pfizer Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Bovine Heparin Product Portfolios and Specifications
Table 80. Pfizer Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. Bioibérica Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 84. Bioibérica Bovine Heparin Product Portfolios and Specifications
Table 85. Bioibérica Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Bioibérica Main Business
Table 87. Bioibérica Latest Developments
Table 88. Opocrin Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 89. Opocrin Bovine Heparin Product Portfolios and Specifications
Table 90. Opocrin Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Opocrin Main Business
Table 92. Opocrin Latest Developments
Table 93. Yino Pharma Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 94. Yino Pharma Bovine Heparin Product Portfolios and Specifications
Table 95. Yino Pharma Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Yino Pharma Main Business
Table 97. Yino Pharma Latest Developments
Table 98. Cisen Pharmaceutical Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 99. Cisen Pharmaceutical Bovine Heparin Product Portfolios and Specifications
Table 100. Cisen Pharmaceutical Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Cisen Pharmaceutical Main Business
Table 102. Cisen Pharmaceutical Latest Developments
Table 103. Sichuan Deebio Pharmaceutical Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 104. Sichuan Deebio Pharmaceutical Bovine Heparin Product Portfolios and Specifications
Table 105. Sichuan Deebio Pharmaceutical Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Sichuan Deebio Pharmaceutical Main Business
Table 107. Sichuan Deebio Pharmaceutical Latest Developments
Table 108. Shenzhen Hepalink Pharmaceutical Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 109. Shenzhen Hepalink Pharmaceutical Bovine Heparin Product Portfolios and Specifications
Table 110. Shenzhen Hepalink Pharmaceutical Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Shenzhen Hepalink Pharmaceutical Main Business
Table 112. Shenzhen Hepalink Pharmaceutical Latest Developments
Table 113. Yantai Dongcheng Pharmaceutical Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 114. Yantai Dongcheng Pharmaceutical Bovine Heparin Product Portfolios and Specifications
Table 115. Yantai Dongcheng Pharmaceutical Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Yantai Dongcheng Pharmaceutical Main Business
Table 117. Yantai Dongcheng Pharmaceutical Latest Developments
Table 118. Nanjing King-friend Biochemical Pharmaceutical Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 119. Nanjing King-friend Biochemical Pharmaceutical Bovine Heparin Product Portfolios and Specifications
Table 120. Nanjing King-friend Biochemical Pharmaceutical Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Nanjing King-friend Biochemical Pharmaceutical Main Business
Table 122. Nanjing King-friend Biochemical Pharmaceutical Latest Developments
Table 123. Hebei Changshan Biochemical Pharmaceutical Basic Information, Bovine Heparin Manufacturing Base, Sales Area and Its Competitors
Table 124. Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Product Portfolios and Specifications
Table 125. Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Hebei Changshan Biochemical Pharmaceutical Main Business
Table 127. Hebei Changshan Biochemical Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Bovine Heparin
Figure 2. Bovine Heparin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bovine Heparin Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Bovine Heparin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Bovine Heparin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Unfractionated Heparin
Figure 10. Product Picture of Low Molecular Weight Heparin
Figure 11. Global Bovine Heparin Sales Market Share by Type in 2022
Figure 12. Global Bovine Heparin Revenue Market Share by Type (2018-2023)
Figure 13. Bovine Heparin Consumed in Hospital
Figure 14. Global Bovine Heparin Market: Hospital (2018-2023) & (Tons)
Figure 15. Bovine Heparin Consumed in Clinics
Figure 16. Global Bovine Heparin Market: Clinics (2018-2023) & (Tons)
Figure 17. Bovine Heparin Consumed in Others
Figure 18. Global Bovine Heparin Market: Others (2018-2023) & (Tons)
Figure 19. Global Bovine Heparin Sales Market Share by Application (2022)
Figure 20. Global Bovine Heparin Revenue Market Share by Application in 2022
Figure 21. Bovine Heparin Sales Market by Company in 2022 (Tons)
Figure 22. Global Bovine Heparin Sales Market Share by Company in 2022
Figure 23. Bovine Heparin Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Bovine Heparin Revenue Market Share by Company in 2022
Figure 25. Global Bovine Heparin Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Bovine Heparin Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Bovine Heparin Sales 2018-2023 (Tons)
Figure 28. Americas Bovine Heparin Revenue 2018-2023 ($ Millions)
Figure 29. APAC Bovine Heparin Sales 2018-2023 (Tons)
Figure 30. APAC Bovine Heparin Revenue 2018-2023 ($ Millions)
Figure 31. Europe Bovine Heparin Sales 2018-2023 (Tons)
Figure 32. Europe Bovine Heparin Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Bovine Heparin Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa Bovine Heparin Revenue 2018-2023 ($ Millions)
Figure 35. Americas Bovine Heparin Sales Market Share by Country in 2022
Figure 36. Americas Bovine Heparin Revenue Market Share by Country in 2022
Figure 37. Americas Bovine Heparin Sales Market Share by Type (2018-2023)
Figure 38. Americas Bovine Heparin Sales Market Share by Application (2018-2023)
Figure 39. United States Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Bovine Heparin Sales Market Share by Region in 2022
Figure 44. APAC Bovine Heparin Revenue Market Share by Regions in 2022
Figure 45. APAC Bovine Heparin Sales Market Share by Type (2018-2023)
Figure 46. APAC Bovine Heparin Sales Market Share by Application (2018-2023)
Figure 47. China Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Bovine Heparin Sales Market Share by Country in 2022
Figure 55. Europe Bovine Heparin Revenue Market Share by Country in 2022
Figure 56. Europe Bovine Heparin Sales Market Share by Type (2018-2023)
Figure 57. Europe Bovine Heparin Sales Market Share by Application (2018-2023)
Figure 58. Germany Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Bovine Heparin Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Bovine Heparin Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Bovine Heparin Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Bovine Heparin Sales Market Share by Application (2018-2023)
Figure 67. Egypt Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Bovine Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Bovine Heparin in 2022
Figure 73. Manufacturing Process Analysis of Bovine Heparin
Figure 74. Industry Chain Structure of Bovine Heparin
Figure 75. Channels of Distribution
Figure 76. Global Bovine Heparin Sales Market Forecast by Region (2024-2029)
Figure 77. Global Bovine Heparin Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Bovine Heparin Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Bovine Heparin Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Bovine Heparin Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Bovine Heparin Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のウシヘパリン市場予測 2023年-2029年] (コード：LP23DC00501)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のウシヘパリン市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のウシヘパリン市場予測 2023年-2029年
  • 世界のウシ心膜パッチ市場予測 2023年-2029年
  • 世界のナドロパリンカルシウム注射市場予測 2023年-2029年
  • 世界の自動乾式生化学分析装置市場予測 2023年-2029年
  • 世界のキサンタンガム市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆